Organigram invests up to $8M in Phylos Bioscience to commercialize THCV products

Mugglehead
By Rowan DunneMay 30, 2023, 5:24 pm188 pts
Toronto’s Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has made its first American investment by partnering with a seed genetics company that will help it market products infused with a rare cannabinoid. On Thursday, Organigram announced that it would be investing up to $8 million in Portland Oregon’s…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Fluence Debuts SPYDR 3: Pioneering Fixture Upgrades Output and Efficiency for Cannabis Growers 68

Legal Pot Delivery 101: A Beginner’s Guide to Cannabis at Your Door 63

Lawmakers urge Trump to act on cannabis 63

Reviewing trends in cannabis-related hospitalizations and emergency department visits in Canada 50

Grön, Head Change Debut Exclusive Solventless Edibles in Missouri 32

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.